<DOC>
	<DOCNO>NCT01616511</DOCNO>
	<brief_summary>The objective study demonstrate long-term safety performance ATI Neurostimulation System use stimulation sphenopalatine ganglion ( SPG ) cluster headache subject .</brief_summary>
	<brief_title>Pathway CH-1 Long-Term Follow-Up</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Subject implant ATI Neurostimulator part Pathway CH1 trial . Subject complete Pathway CH1 Open Label Final office visit remain implanted ATI Neurostimulator . Subject ability read , comprehend reliably record information require Protocol . Subject able provide write informed consent prior participation study . Subject require pacemaker/defibrillator implantable device sense amplifier program 'On . ' Subject suitable study reason judgment Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>